J&J also raised its full-year revenue guidance to include sales of the psychiatric drug Caplyta, which the company got from its acquisition of Intra-Cellular Therapies. It maintained its full-year ...

Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company advancing novel solutions in immunology and oncology, today announced the appointment of Vincent LoPriore, Founder of Gravitas ...

Colossal Biosciences, an American biotechnology company, announced the "de-extinction" of the dire wolf, a prehistoric wolf species that died out more than 10,000 years ago, in April 2025. Three pups ...

Pfizer Inc.'s (PFE) decision to halt the development of its oral GLP-1 candidate due to a potential liver toxicity issue could pose tailwinds for smaller biotech rivals, according to Wall Street ...

The moves, announced Monday in the Federal Register, are a precursor to imposing tariffs and threaten to broaden the president’s sweeping US trade war ...

The much-publicized introduction of genetically modified cubs that share features of extinct dire wolves sparked claims ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

A team discovers a new family of enzymes capable of inducing targeted cuts in single-stranded DNA A few years ago, the advent of technology known as CRISPR was a major breakthrough in the scientific ...

Bipartisan congressional commission introduces legislation to coordinate emerging biotechnology research and boost investment ...

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...